close android install prompt
Device Showcase
Download the app!
INSTALL
Evidence Central
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
Log in
Refine your search:
27All Results
Evidence-Based Medicine GuidelinesEvidence-Based Medicine Guidelines
EE+ POEM ArchiveEE+ POEM Archive
Cochrane AbstractsCochrane Abstracts
Phosphodiesterase inhibitors for erectile dysfunction
27 results
1 - 27
  • EBMG Phosphodiesterase inhibitors for erectile dysfunction
    • Evidence Summaries
    • References
  • CochranePhosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
    • Abstract
    • Reviewer's Conclusions
  • EBMG Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
    • Evidence Summaries
    • References
  • CochraneSildenafil citrate for erectile dysfunction in patients with multiple sclerosis: Cochrane systematic review
    • Abstract
  • CochraneNon‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea
    • Abstract
    • Reviewer's Conclusions
  • infoPOEMsRisk of melanoma increases minimally, if at all, with the use of PDE5 inhibitors
    • Bottom Line
    • Reference
  • CochraneInterventions for treating sexual dysfunction in patients with chronic kidney disease: Cochrane systematic review
    • Abstract
    • Summary
  • CochraneGinseng for erectile dysfunction
    • Abstract
  • CochranePenile rehabilitation for postprostatectomy erectile dysfunction
    • Abstract
    • Reviewer's Conclusions
  • CochraneTestosterone replacement in men with sexual dysfunction
    • Abstract
    • Reviewer's Conclusions
  • CochraneStrategies for managing sexual dysfunction induced by antidepressant medication
    • Abstract
  • CochranePhosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon
    • Abstract
  • EBMG Benign prostatic hyperplasia
    • Conservative treatment
  • EBMG Erectile dysfunction
    • Treatment
  • CochranePhosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
    • Abstract
  • 1 - 27 of 27 records
Your free 1 year of online access expired  .

Want to regain access to Evidence Central?

Log in to Evidence Central

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
A Evidence Central subscription is required to
Already have an account?Log In
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

© 2000–2025 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebookinstagramyoutubeLinkedIn

25.08.19-25.08.19_06